首页 > 市场调查报告书 > 製药

生技设备生物工艺

欧洲生物加工市场预测至 2031 年 - 区域分析 - 按产品、营运规模、製程、应用和最终用户

市场调查报告书

商品编码

1597074

欧洲生物加工市场预测至 2031 年 - 区域分析 - 按产品、营运规模、製程、应用和最终用户

Europe Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product, Scale of Operation, Process, Application, and End User

出版日期: 2024年10月03日 | 出版商:

The Insight Partners | 英文 167 Pages | 订单完成后即时交付

价格

简介目录图表

2023年欧洲生物加工市场价值为62.165亿美元，预计到2031年将达到168.0347亿美元；预计2023年至2031年复合年增长率为13.2%。

不断成长的生物製药产业推动欧洲生物加工市场

在生物製药产业，始终需要改进的生物製程来解决新的监管要求、品质控制要求以及生物製品、细胞培养滴定和生物仿製药生产中的生产问题。近年来，生物製药产业以前所未有的速度成长。生物製药公司正在研发上花费巨额资金，以推出具有增强的医疗和商业效力的新分子，用于各种治疗应用。由于生物製程在生物製剂和生物相似药的研究、开发和製造中的广泛应用，其接受度逐渐提高。大型製药公司和合约研究组织正在开发新的药物和治疗形式来治疗多种适应症。此外，对治疗慢性病的生物製剂和生物相似药的强劲需求反过来又推动了生物製药行业的成长。生物製药产业是对经济最重要的贡献者之一。生物製品批准增加、生物仿製药管道不断增加、研究活动投资增加以及对开发负担得起的生物製品的日益关注等因素正在促进生物製药行业的增长。

除此之外，基因和细胞疗法的批准不断增加有利于生物加工市场的成长。核准的基因疗法有 Glybera（用于治疗脂蛋白脂肪酶缺乏症）和 Strimvelis（用于治疗 ADA 严重复合型免疫缺陷症）。因此，上述因素增加了对各种治疗药物大规模生产的需求，从而促进了生物加工市场的成长。

欧洲生物加工市场概况

生物相似药引入了竞争并提高了生物製剂的可负担性，最终提供节省成本和增值服务来支持患者护理和医疗保健行业。医疗保健专业人员可以以更低的成本使用高品质的生物製剂治疗更多患者。由于节省成本的巨大潜力，德国卫生部推出了一项新法律来增加生物相似药的采用。此外，国际参与者之间越来越多的合作伙伴关係也促进了该国市场的成长。例如，2020 年 11 月，Hitachi Chemical Advanced Therapeutics Solutions, LLC 和 apceth Biopharma GmbH 扩大了与 Bluebird Bio 的关係，签订长期开发和製造服务协议，用于多种疗法的临床和商业供应，并扩大商业药物ZYNTEGLO在欧洲的产品生产能力，这是一种用于输血依赖性β-地中海贫血（TDT）的一次性基因疗法。此外，由于众多生技公司、高科技研究实验室以及大量的研发资金的存在，德国的生物技术产业呈现出巨大的成长。生物製药和生物製剂研发的成长主要是由医疗保健产业公司采用各种有机策略所推动的。例如，2021 年 6 月，Rentschler Biopharma 扩建了 2,000 公升生物反应器的产能，以满足对复杂抗体不断增长的需求，复杂抗体是一类具有持续高潜力的生物製药药物。同样，2023 年8 月，生物製药行业领先供应商之一赛多利斯与全球技术和软体领导者艾默生合作，将赛多利斯的Biostat STR 第3 代系列生物反应器与艾默生的DeltaVTM 分散式控制系统(DCS) 整合。因此，由于生物製药公司研发支出的增加，该国的生物製药产业正在成长。因此，该国生物製药和生物技术公司的合作研究努力影响市场。

欧洲生物加工市场收入及 2031 年预测（百万美元）

欧洲生物加工市场细分

欧洲生物加工市场按产品、经营规模、製程、应用、最终用户和国家分类。

根据产品，欧洲生物加工市场分为仪器和消耗品及配件。到2023年，仪器仪表领域将占据更大的市场份额。此外，生物反应器细分分为中试规模、全规模和实验室规模。此外，分段层析系统又分为液相层析、气相层析等。此外，消耗品和配件细分为试剂、细胞培养基、层析树脂等。

从营运规模来看，欧洲生物加工市场分为商业营运和临床营运。 2023年，商业营运领域占据更大的市场份额。

依製程划分，欧洲生物加工市场分为下游生物製程和上游生物製程。到2023年，下游生物製程领域将占据更大的市场份额。

根据应用，欧洲生物加工市场分为单株抗体、疫苗、重组蛋白、细胞和基因治疗等。 2023 年，单株抗体细分市场占最大市场。

就最终用户而言，欧洲生物加工市场分为生物製药公司、合约製造组织等。 2023 年，生物製药公司细分市场占最大市场。

按国家/地区划分，欧洲生物加工市场分为德国、法国、义大利、英国、西班牙和欧洲其他地区。 2023 年，德国在欧洲生物加工市场份额中占据主导地位。

Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Repligen Corp、Entegris Inc、Agilent Technologies Inc 和 Cytiva US LLC。是欧洲生物加工市场上的一些领先公司。

In the biopharmaceutical industry, improved bioprocesses are always in demand to address new regulatory requirements, quality control requirements, and production issues in biological products, cell culture titration, and biosimilar production. In recent years, the biopharmaceutical industry has been growing at an unprecedented pace. Biopharmaceutical companies are spending huge sums in R&D to introduce new molecules with enhanced medical and commercial potency for various therapeutic applications. The acceptance of bioprocessing is gradually increasing due to its wide application in research, development, and manufacturing of biologics and biosimilars. Big pharmaceutical companies and contract research organizations are coming up with new medicines and therapy forms to treat a wide range of indications. Further, a strong demand for biologics and biosimilars to treat chronic diseases is, in turn, driving the growth of the biopharmaceutical industry. The biopharmaceutical industry is one of the most significant contributors to the economy. Factors such as increasing biologics approval, growing biosimilar pipeline, rising investment in research activities, and increasing focus on developing affordable biologics are facilitating the growth of the biopharmaceutical industry.

Apart from these, increasing approvals in gene and cell therapies are favoring the bioprocessing market growth. The approved gene therapies are Glybera (to treat lipoprotein lipase deficiency) and Strimvelis (to treat ADA-severe combined immunodeficiency). Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioprocessing market.

Europe Bioprocessing Market Overview

Biosimilars introduce competition and increase the affordability of biologics, which ultimately deliver savings and value-added services to support patient care and the healthcare industry. Healthcare professionals can treat more patients with high-quality biologics at reduced cost. Due to the massive potential for cost savings, the German Health Ministry introduced a new law to increase the adoption of biosimilars. Also, a growing number of partnerships among international players boost the market growth in the country. For instance, in November 2020, Hitachi Chemical Advanced Therapeutics Solutions, LLC and apceth Biopharma GmbH expanded their relationship with Bluebird Bio to enter into long-term development and manufacturing services agreements for clinical and commercial supply of multiple therapies, as well as expand commercial drug product manufacturing capacity in Europe for ZYNTEGLO, a one-time gene therapy for transfusion-dependent-thalassemia (TDT). Further, the biotechnology sector in Germany exhibits tremendous growth owing to the presence of numerous biotechnology companies, high-tech research labs, and massive funding for research and development. The growth of research and development in biopharmaceuticals and biologics is majorly driven by the adoption of various organic strategies by companies in the healthcare industry. For instance, in June 2021, Rentschler Biopharma expanded its production capacity with a 2,000-liter bioreactor to address the increasing demand for complex antibodies, a class of biopharmaceutical drugs with continued high potential. Likewise, in August 2023, Sartorius, one of the leading suppliers for the biopharmaceutical industry, collaborated with global technology and software leader Emerson to integrate Sartorius's Biostat STR Generation 3 family of bioreactors with Emerson's DeltaVTM distributed control system (DCS). Thus, the biopharmaceutical sector in the country is growing due to increasing R&D expenditure by biopharmaceutical companies. Thus, collaborative research efforts by biopharmaceutical and biotechnology companies in the country influence the market.

Europe Bioprocessing Market Revenue and Forecast to 2031 (US$ Million)

Europe Bioprocessing Market Segmentation

The Europe bioprocessing market is categorized into product, scale of operation, process, application, end user, and country.

Based on product, the Europe bioprocessing market is bifurcated into instruments and consumables & accessories. The instruments segment held a larger market share in 2023. Furthermore, the instruments segment is sub segmented into filtration devices, bioreactors, chromatography systems, centrifuge, drying devices, and others. Additionally, the bioreactors subsegment is categorized into pilot scale, full scale, and laboratory scale. Furthermore, the subsegment chromatography systems is segmented into liquid chromatography, gas chromatography, and others. Additionally, the consumables & accessories segment is sub segmented into reagents, cell culture media, chromatography resins, and others.

In terms of scale of operation, the Europe bioprocessing market is bifurcated into commercial operations and clinical operations. The commercial operations segment held a larger market share in 2023.

By process, the Europe bioprocessing market is bifurcated into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023.

Based on application, the Europe bioprocessing market is categorized into monoclonal antibodies, vaccines, recombinant protein, cell & gene therapy, and others. The monoclonal antibodies segment held the largest market share in 2023.

In terms of end user, the Europe bioprocessing market is categorized into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest market share in 2023.

By country, the Europe bioprocessing market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe bioprocessing market share in 2023.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc, and Cytiva US LLC. are some of the leading companies operating in the Europe bioprocessing market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Bioprocessing Market Landscape

4.1 Ecosystem Analysis
- 4.1.1 List of Vendors in the Value Chain

5. Europe Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
- 5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
- 5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - Europe Analysis

6.1 Europe Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. Europe Bioprocessing Market Analysis - by Product

7.1 Overview
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
    - 7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
    - 7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
- 7.3.1 Overview
- 7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. Europe Bioprocessing Market Analysis - by Scale of Operation

8.1 Overview
8.2 Commercial Operations
- 8.2.1 Overview
- 8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
- 8.3.1 Overview
- 8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Bioprocessing Market Analysis - by Process

9.1 Overview
9.2 Downstream Bioprocess
- 9.2.1 Overview
- 9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
- 9.3.1 Overview
- 9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Bioprocessing Market Analysis - by Application

10.1 Overview
10.2 Monoclonal Antibodies
- 10.2.1 Overview
- 10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
- 10.3.1 Overview
- 10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
- 10.4.1 Overview
- 10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
- 10.5.1 Overview
- 10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Bioprocessing Market Analysis - by End User

11.1 Overview
11.2 Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
- 11.3.1 Overview
- 11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Bioprocessing Market - Country Analysis

12.1 Europe
- 12.1.1 Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
  - 12.1.1.1 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Overview
  - 12.1.1.2 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 Germany: Bioprocessing Market Breakdown, by Product
    - 12.1.1.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.2.2 Germany: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.2.3 Germany: Bioprocessing Market Breakdown, by Process
    - 12.1.1.2.4 Germany: Bioprocessing Market Breakdown, by Application
    - 12.1.1.2.5 Germany: Bioprocessing Market Breakdown, by End User
  - 12.1.1.3 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Overview
  - 12.1.1.4 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
    - 12.1.1.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
    - 12.1.1.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
    - 12.1.1.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
  - 12.1.1.5 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.5.1 Overview
  - 12.1.1.6 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.6.1 France: Bioprocessing Market Breakdown, by Product
    - 12.1.1.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.6.1.2 France: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.6.2 France: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.6.3 France: Bioprocessing Market Breakdown, by Process
    - 12.1.1.6.4 France: Bioprocessing Market Breakdown, by Application
    - 12.1.1.6.5 France: Bioprocessing Market Breakdown, by End User
  - 12.1.1.7 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.7.1 Overview
  - 12.1.1.8 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.8.1 Italy: Bioprocessing Market Breakdown, by Product
    - 12.1.1.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.8.3 Italy: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.8.4 Italy: Bioprocessing Market Breakdown, by Process
    - 12.1.1.8.5 Italy: Bioprocessing Market Breakdown, by Application
    - 12.1.1.8.6 Italy: Bioprocessing Market Breakdown, by End User
  - 12.1.1.9 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.9.1 Overview
  - 12.1.1.10 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.10.1 Spain: Bioprocessing Market Breakdown, by Product
    - 12.1.1.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.10.2 Spain: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.10.3 Spain: Bioprocessing Market Breakdown, by Process
    - 12.1.1.10.4 Spain: Bioprocessing Market Breakdown, by Application
    - 12.1.1.10.5 Spain: Bioprocessing Market Breakdown, by End User
  - 12.1.1.11 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.11.1 Overview
  - 12.1.1.12 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
    - 12.1.1.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
    - 12.1.1.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.1.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.1.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables & Accessories
    - 12.1.1.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.1.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
    - 12.1.1.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
    - 12.1.1.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sartorius AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Corning Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 3M Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Eppendorf SE
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Repligen Corp
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Entegris Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Agilent Technologies Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Cytiva US LLC
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market

List Of Figures

Figure 1. Europe Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Europe: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market